Wells Fargo's Mohit Bansal: Abbvie has better long-term opportunity than Bristol-Myers

In this video

Share

Wells Fargo's Mohit Bansal: Abbvie has better long-term opportunity than Bristol-Myers

Mohit Bansal, Wells Fargo, joins 'Closing Bell' to discuss Bristol-Myers shares rising on the FDA approval of its latest drug. Wells Fargo Securities maintains a market in the common stock of Bristol-Myers Squibb Company.
03:07
Mon, Sep 12 20224:20 PM EDT